Dr Marvin Barco Mata, MD | |
211 4th St, Alexandria, LA 71301-8421 | |
(315) 464-5800 | |
Not Available |
Full Name | Dr Marvin Barco Mata |
---|---|
Gender | Male |
Speciality | Pediatrics - Pediatric Critical Care Medicine |
Location | 211 4th St, Alexandria, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124281852 | NPI | - | NPPES |
1124281852 | Other | LA | BLUE CROSS BLUE SHIELD |
2120336 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0203X | Pediatrics - Pediatric Critical Care Medicine | MD203581 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Marvin Barco Mata, MD 5445 Provine Place, Apartment 1608, Alexandria, LA 71303-3700 Ph: () - | Dr Marvin Barco Mata, MD 211 4th St, Alexandria, LA 71301-8421 Ph: (315) 464-5800 |
News Archive
The World Health Organization (WHO) has released its "to-do" list of the most urgent worldwide health issues that need to be tackled over the next decade. The heart of the issue, argues the WHO, is that governments are simply failing to fund health needs and health care systems. As a result, they are putting many people at the risk of death, poverty and of a national economic downturn.
Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin Smart Catheter technology portfolio.
The possibility of developing stem cells from a patient's own skin and using them to treat conditions as diverse as Parkinson's disease, Alzheimer's disease and cancer has generated tremendous excitement in the stem cell research community in recent years. Such therapies would avoid the controversial need for using stem cells derived from human embryos, and in theory, also bypass immunological problems inherent in using cells from one person to treat another.
Preclinical research from VCU Massey Cancer Center published recently in the Proceedings of the National Academy of Sciences shows that the combination of two existing drugs can exploit the metabolic "hunger" of a particularly aggressive type of neuroblastoma to kill cancer cells without inflicting too much collateral damage to healthy tissue.
› Verified 6 days ago
Zulma Nahir Laracuente, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 176 Versailles Blvd, Alexandria, LA 71303 Phone: 318-445-9331 Fax: 318-619-6899 | |
Dr. John N. Rhodes, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2226 Worley Dr, Alexandria, LA 71301 Phone: 318-443-9634 Fax: 318-443-9809 | |
Dr. Blaine Mark Broussard, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 176 Versailles Blvd, Alexandria, LA 71303 Phone: 318-445-9331 Fax: 318-619-6899 | |
Ahmed Mamilly, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 501 Medical Center Dr Ste 3a, Alexandria, LA 71301 Phone: 318-484-3899 Fax: 318-484-3887 | |
Dr. Yasser M Nakhlawi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3311 Prescott Rd, Suite 210, Alexandria, LA 71301 Phone: 318-487-1477 Fax: 318-442-5814 | |
Dr. Sonji Joell Chinagozi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3807 Prescott Road, Alexandria, LA 71301 Phone: 318-528-8902 Fax: 318-528-8901 |